IP Library Granted Patent US 10,538,518
Granted Patent B2
US 10,538,518 · App. 15/748,212 · Granted Jan 21, 2020

Processes for preparing an FGFR inhibitor

Inventors: Jiang Zhu (San Ramon, CA); Mohammad Masjedizadeh (San Jose, CA)
Assignee: Principia Biopharma, Inc.
C07D471/04A61P35/00C07B35/02C07B35/06C07B39/00C07B43/04C07B43/06C07B45/04C07B2200/13
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,538,518
App. No.
15/748,212
Granted
Jan 21, 2020
Kind
B2
Abstract

To an appropriate reactor equipped with mechanical stirrer was charged acetic acid (12 L), tert-butyl 4-(3-(6-(3,5-dimethoxyphenyl)-2-(methylthio)-7-oxopyrido[2,3-d]pyrimidin-8(7H)-yl)propyl)piperazine-1-carboxylate (2000 g) and triethylamine (639 g, 2.3 eq.). Internal temperature was adjusted to approximately 20° C. and N-chlorosuccinimide (1651 g, 4.5 eq.) was added at 20-30° C. Reaction was stirred for 2 hours. Ethyl acetate (30 L) was added. 5% aqueous NaCl solution (20 L) was added. The organic layer was separated and the aqueous layer was extracted with EtOAc. The combined organic layers were washed with 30% aqueous potassium carbonate solution (14 L). The organic layer was concentrated to ˜12 L and used for next step directly.

Claims (25)

1. A process of preparing a compound of formula (1):

comprising:

(G) reacting a compound of formula (e):

where R is alkyl; with a compound of formula (f):

and

(H) treating a compound of formula (g) formed in situ

from the reaction of compound (e) and (f) with a compound of formula (h) or a salt thereof

under alkylating reaction conditions to provide a compound of formula (1), where PG in formula (1) and formula (h) is an amino protecting group.

2. The process of claim 1 wherein Step G is carried out in the presence of a base, and in a polar organic solvent.

3. The process of claim 1 wherein the process of Step H is carried out in the presence of a base and in a polar organic solvent.

4. A process for preparing a compound of formula (2) and/or (3):

comprising reacting a compound of formula (1):

with a N-chlorosuccinimide (NCS) to provide the compound of formula (2) and/or (3):

where PG is an amino protecting group.

5. A process for preparing a compound of formula (4):

comprising treating a compound of formula (2) and/or (3):

with methylamine to give the compound of formula (4)

6. A process for preparing a compound of formula (5):

or a salt thereof; comprising removing the amino protecting group “PG” of compound (4)

to give the compound of formula (5):

or a salt thereof.

7. A process of preparing a compound of formula (d) comprising reacting a compound of formula (6) with a compound of formula (iii) where LG is a leaving group under acylating reaction conditions

to give a compound of formula (d); or

reacting a compound of formula (6) with propenoic acid under amide bond formation reaction conditions:

to give a compound of formula (d).

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 29, 2018
From: ZHU, JIANG; MASJEDIZADEH, MOHAMMAD
To: PRINCIPIA BIOPHARMA, INC.
Reel/Frame 044751/0114 →
Continuity (2)
Provisional Application 62203498 · Aug 11, 2015
Related Publication 20180215756A1 · Aug 2, 2018
Cited By (1)
US 12,281,110